On October 13, Astera Labs, Inc. experienced an Overnight decline of 3.09%, trading at $314.1 per share with a turnover of $5.192 million. The downward move follows a recent rating downgrade by Northland Securities, which lowered its recommendation from Outperform to Market Perform, prompting profit-taking pressure ahead of the upcoming earnings call.
The downgrade has notably weighed on short-term sentiment despite the broader analyst consensus remaining constructive, with an average rating of Overweight and a mean price target of $416.78 according to market data. The company is scheduled to report its third quarter fiscal 2026 results on November 3, with market expectations set at an EPS of $0.83.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)